Trial ID or NCT#

NCT01127061

Status

NOT RECRUITING

Purpose

The investigators propose a pilot randomized controlled trial to determine the safety and potential benefits of moderate intensity exercise in patients with hypertrophic cardiomyopathy. The investigators hypotheses are that exercise parameters derived from a baseline cardiopulmonary exercise test will target an appropriately safe level of exercise intensity that will not cause significant arrhythmias or exacerbate symptoms and that exercise training for 4 months will result in significant improvements in peak oxygen consumption and quality of life, with neutral effects on the clinical characteristics.

Official Title

A Randomized Trial of Moderate Intensity Exercise Training in Hypertrophic Cardiomyopathy

Eligibility Criteria

Ages Eligible for Study: 18 Years to 80 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Euan A. Ashley
Cardiologist
Associate Professor of Medicine (Cardiovascular), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology at the Stanford University Medical Center
Matthew Wheeler
Cardiologist
Clinical Assistant Professor, Medicine - Cardiovascular Medicine

Contact us to find out if this trial is right for you.

CONTACT

Heidi Salisbury, RN, MSN
(650) 736-7878